about
Physiological Implications of Myocardial Scar StructureThe human sympathetic nervous system: its relevance in hypertension and heart failureEffect of Scar Compaction on the Therapeutic Efficacy of Anisotropic Reinforcement Following Myocardial Infarction in the Dog.Norepinephrine is required to promote wakefulness and for hypocretin-induced arousal in zebrafish.Medical management of congestive heart failure.Congestive heart failure. New frontiersNeuroendocrine activity in untreated heart failureDecreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function.Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.The Genetic Challenges and Opportunities in Advanced Heart FailureMyocardial beta-adrenergic receptor function during the development of pacing-induced heart failureA comparison of sympathoadrenal activity and cardiac performance at rest and during exercise in patients with ventricular demand or atrial synchronous pacing.Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exerciseType 1/Type 2 immunity in infectious diseases.beta-Blockers in congestive heart failure.Increased production of nitric oxide in coronary arteries during congestive heart failure.Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure.Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations.Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture.Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarctionWhich vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failureHeart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.Vasoconstrictor role for vasopressin in experimental heart failure in the rabbitSodium and water balance in chronic congestive heart failure.Catecholamines 101The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.Functional analysis of desensitization of the beta-adrenoceptor signalling pathway in rat cardiac tissues following chronic isoprenaline infusionG protein coupled receptor kinases as therapeutic targets in cardiovascular disease.Use of beta-blockers in congestive heart failure.Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol.Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatmentEfficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation.Role of intact cardiac nerves and reflex mechanisms in desensitization to catecholamines in conscious dogs.AT(1)-receptor blockade and sympathetic neurotransmission in cardiovascular disease.New developments in the use of beta-blockers for the management of heart failure.The effect of pertussis toxin on beta-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea-pigs and patients with cardiac failure
P2860
Q28085424-5FB3D31A-61B5-4602-B2BA-50AC742A4D8EQ28264609-A942D9E2-496E-4ACE-8A35-88B6809675FEQ30279182-60BF1DDD-32DA-42E0-8CCD-0F80D6783D66Q30401043-B84D7A75-5940-4876-9A0D-D0AB6AFFBA7DQ33558612-19758883-A1EB-47AF-A9AD-4D2973C70C80Q33559075-5D6127A7-74A7-4032-9D4B-55F0D20A0533Q33611263-3A8510AE-2628-45D7-AFA1-4123A71E36F1Q33612068-DC53CCF4-8BC1-4816-925F-7E842AF76747Q33614319-FD1A3D78-F931-4AA3-A9C8-91A9AEA507A6Q33653498-82F9620F-7F3D-4D17-AA50-952A6F615EACQ33892916-A388B095-C139-4130-A472-AB2ABB302BF8Q33999694-A018DD35-C110-4774-A7D3-664A66697726Q34036995-6235BAE8-D41E-4D1C-841D-8850965CA433Q34105379-5950EEBE-DBDA-4AC5-8BDD-7FCF58E2F62BQ34119535-AC42A57E-1969-4A2D-AC0A-E8E26D4C5D2BQ34119551-94470E58-8196-4F88-8449-8FF4003A11E7Q34207430-57EF6ADE-2418-44B1-B8DD-754C1EA0881AQ34249819-0B564B55-4A14-442A-BF6B-56E37D494EA8Q34286019-A84D2C46-BB81-40DC-B388-5D7CA90BD657Q34289204-0F3AAB44-9B29-4303-8A68-183CC0627EFAQ34358252-AEF84085-7905-4A5A-AC11-6AD91C099135Q34397513-9C8AAA2E-D46D-4E1B-8718-8E800215F5E2Q34448373-190EA79C-0612-4904-8BA9-4E99701ABB8AQ34487124-37A9B8F0-2EF1-472A-88AA-B81CFBDD6A30Q34537682-23DF985E-B51D-42F0-AD66-2C189821949DQ34577437-70AF53CB-8AEC-4EF0-ADBC-EA8D31F34ED5Q34611815-0B45C559-E3A5-434B-8E8B-2066FC3D3C74Q34778695-7A7DC87D-6BDC-483B-AD2B-74B959A507E7Q35029026-19A6C951-EE37-4FDD-9EF5-60663FA4C20DQ35135090-3A8DF51B-33EC-467B-9185-6531C6E5B9C9Q35170620-7980417F-64F2-4595-9598-DB6AF051EB87Q35366259-B73056B9-91B1-4A08-974C-6A971FA70D75Q35598979-43CCEA6A-21DD-4F9E-9E3F-39D09E1EE42DQ35755691-E7414A6A-6D0D-4DD8-8FA2-A83DB5FE2755Q35806196-81C68154-0A07-4267-B9FC-3800C1FC9940Q35816081-BB3E9B00-3B49-43D4-9312-D7DAB66A67FCQ35818139-FD830CFF-1EB0-454E-9526-6A6903F8DE94Q35837657-4B3D7480-6359-4B91-BCA5-3CCFE2871E3DQ35842541-6D5BEE7B-B0B7-41BA-8A04-1465A32AF1C4Q35870521-293E196A-FE1E-48FA-A91E-BCD51A15B294
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Plasma norepinephrine in congestive heart failure.
@en
type
label
Plasma norepinephrine in congestive heart failure.
@en
prefLabel
Plasma norepinephrine in congestive heart failure.
@en
P1476
Plasma norepinephrine in congestive heart failure.
@en
P2093
P304
P356
10.1016/0002-9149(78)90162-5
P407
P577
1978-02-01T00:00:00Z